Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
CAPRICOR THERAPEUTICS, INC. roe for the quarter ending 2026-06-30 was -52.56%, a change of 14.10% year-over-year.
CAPRICOR THERAPEUTICS, INC. roe for the quarter ending 2026-03-31 was -41.12%, a change of 2.02% year-over-year.
CAPRICOR THERAPEUTICS, INC. roe for the quarter ending 2025-12-31 was -34.35%, a change of -6.53% year-over-year.
CAPRICOR THERAPEUTICS, INC. roe for the quarter ending 2025-09-30 was -97.76%, a change of -47.79% year-over-year.
CAPRICOR THERAPEUTICS, INC. roe for fiscal 2025 was -34.35%, a change of -6.53% from fiscal 2024.
CAPRICOR THERAPEUTICS, INC. roe for fiscal 2024 was -27.82%, a change of 70.79% from fiscal 2023.
CAPRICOR THERAPEUTICS, INC. roe for fiscal 2023 was -98.61%, a change of 147.61% from fiscal 2022.
CAPRICOR THERAPEUTICS, INC. roe for fiscal 2022 was -246.22%, a change of -182.39% from fiscal 2021.